PTSM: Pharmaceutical Technology Sourcing and Management, Jul 13, 2007 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
PTSM: Pharmaceutical Technology Sourcing and Management, Jul 13, 2007
Global Feature
Changing Patterns for Global Pharmaceutical Growth
By Patricia Van Arnum
Although North America accounts for the largest share of the pharmaceutical market, Brazil, China, India, Indonesia, Mexico, Russia, and Turkey are projected to account for almost one-fifth of the global market by 2020. The rising participation in select countries' drug-development activities is evident by recent investment and outsourcing by the pharmaceutical majors.
News
Mergers, acquisitions, and restructuring
A roundup of company moves and positioning from the pharmaceutical and biotechnology industries and contract service providers.
Expansions
A roundup of manufacturing and service expansions.
Agreements and contracts
The latest pacts from the pharmaceutical supply chain.
API watch
The latest on active pharmaceutical ingredients in development and under commercial manufacture.
Regulatory and association news
Developments from the US Food and Drug Administration, European Medicines Agency, and other key regulatory bodies and news from key trade associations.
People
People on the move.
Outsourcing
Stall Out in R&D Outsourcing
By Jim Miller
An industry survey finds that pharma's outsourcing practices keep the industry from reaping the full benefits of outsourcing.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here